Why the study?
Chemotherapeutic drugs have improved cancer outcomes but caused an increasing incidence of cardiovascular complications, notably cardiotoxicity presenting as left ventricular systolic dysfunction.
This review highlights the increasing incidence of cardiovascular side effects from chemotherapeutic drugs and discusses current treatment options and evidence gaps for cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Warrants cardiac monitoring for LV dysfunction during chemotherapy; leaves open optimal cardioprotection amid evidence gaps.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: